IFN-alpha/beta R1產(chǎn)品信息
英文名稱:Interferon-alpha/beta receptor alpha chain
中文名稱:干擾素α/β受體α鏈
靶點(diǎn)別稱:IFNAR1,IFNAR,CRF2-1,IFN-R-1,IFNAR-1
物種:Human/Mouse/Cynomolgus
屬性:Protein
標(biāo)記:Protein-coupled magnetic beads/Biotin-labeled/Unconjugated
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>90% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
IFN-alpha/beta R1分子背景
干擾素α/β受體1(IFNAR1)也稱為細(xì)胞因子受體II類成員1、細(xì)胞因子受體家族2成員1(CRF2-1)、I型干擾素受體1、IFNAR,屬于II型細(xì)胞因子受體族。IFNAR1/IFNAR包含四個(gè)纖維連接蛋白III型結(jié)構(gòu)域。IFNAR1與IFNAR2結(jié)合形成I型干擾素受體。IFNAR1是干擾素α和β的受體。IFNAR1可以在沒有IFNAR2的幫助下轉(zhuǎn)導(dǎo)IFNB信號(hào),并且不會(huì)激活Jak-STAT通路。
關(guān)鍵字: IFN-alpha/beta R1;IFN-alpha/beta R1蛋白;IFN-alpha;IFN-beta R1;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。